Global Prostate Cancer Diagnostics and Therapy Market Insights, Forecast to 2028

TABLE OF CONTENTS

1 Report Business Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Treatment Method
  • 1.2.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Treatment Method, 2017 VS 2021 VS 2028
  • 1.2.2 Androgen Receptor-Directed Therapy
  • 1.2.3 Taxane-Based Chemotherapy
• 1.3 Market by Application
  • 1.3.1 Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
  • 1.3.2 Hospitals
  • 1.3.3 Clinics
  • 1.3.4 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Prostate Cancer Diagnostics and Therapy Market Perspective (2017-2028)
• 2.2 Prostate Cancer Diagnostics and Therapy Growth Trends by Region
  • 2.2.1 Prostate Cancer Diagnostics and Therapy Market Size by Region: 2017 VS 2021 VS 2028
  • 2.2.2 Prostate Cancer Diagnostics and Therapy Historic Market Size by Region (2017-2022)
  • 2.2.3 Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2023-2028)
• 2.3 Prostate Cancer Diagnostics and Therapy Market Dynamics
  • 2.3.1 Prostate Cancer Diagnostics and Therapy Industry Trends
  • 2.3.2 Prostate Cancer Diagnostics and Therapy Market Drivers
  • 2.3.3 Prostate Cancer Diagnostics and Therapy Market Challenges
  • 2.3.4 Prostate Cancer Diagnostics and Therapy Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue
  • 3.1.1 Global Top Prostate Cancer Diagnostics and Therapy Players by Revenue (2017-2022)
  • 3.1.2 Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Players (2017-2022)
• 3.2 Global Prostate Cancer Diagnostics and Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.3 Players Covered: Ranking by Prostate Cancer Diagnostics and Therapy Revenue
• 3.4 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio
  • 3.4.1 Global Prostate Cancer Diagnostics and Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Prostate Cancer Diagnostics and Therapy Revenue in 2021
• 3.5 Prostate Cancer Diagnostics and Therapy Key Players Head office and Area Served
• 3.6 Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
• 3.7 Date of Enter into Prostate Cancer Diagnostics and Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Prostate Cancer Diagnostics and Therapy Breakdown Data by Treatment Method

• 4.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Treatment Method (2017-2022)
• 4.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Treatment Method (2023-2028)

5 Prostate Cancer Diagnostics and Therapy Breakdown Data by Application

• 5.1 Global Prostate Cancer Diagnostics and Therapy Historic Market Size by Application (2017-2022)
• 5.2 Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2023-2028)

6 North America

• 6.1 North America Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
• 6.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method
  • 6.2.1 North America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)
  • 6.2.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028)
  • 6.2.3 North America Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method (2017-2028)
• 6.3 North America Prostate Cancer Diagnostics and Therapy Market Size by Application
  • 6.3.1 North America Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)
  • 6.3.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028)
  • 6.3.3 North America Prostate Cancer Diagnostics and Therapy Market Share by Application (2017-2028)
• 6.4 North America Prostate Cancer Diagnostics and Therapy Market Size by Country
  • 6.4.1 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
  • 6.4.2 North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
• 7.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method
  • 7.2.1 Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)
  • 7.2.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028)
  • 7.2.3 Europe Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method (2017-2028)
• 7.3 Europe Prostate Cancer Diagnostics and Therapy Market Size by Application
  • 7.3.1 Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)
  • 7.3.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028)
  • 7.3.3 Europe Prostate Cancer Diagnostics and Therapy Market Share by Application (2017-2028)
• 7.4 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country
  • 7.4.1 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
  • 7.4.2 Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic Countries

8 Asia-Pacific

• 8.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
• 8.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method
  • 8.2.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)
  • 8.2.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028)
  • 8.2.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method (2017-2028)
• 8.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Application
  • 8.3.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)
  • 8.3.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028)
  • 8.3.3 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Share by Application (2017-2028)
• 8.4 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region
  • 8.4.1 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022)
  • 8.4.2 Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2023-2028)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
• 9.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method
  • 9.2.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)
  • 9.2.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028)
  • 9.2.3 Latin America Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method (2017-2028)
• 9.3 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Application
  • 9.3.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)
  • 9.3.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028)
  • 9.3.3 Latin America Prostate Cancer Diagnostics and Therapy Market Share by Application (2017-2028)
• 9.4 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country
  • 9.4.1 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
  • 9.4.2 Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size (2017-2028)
• 10.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method
  • 10.2.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022)
  • 10.2.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028)
  • 10.2.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method (2017-2028)
• 10.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Application
  • 10.3.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022)
  • 10.3.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028)
  • 10.3.3 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Share by Application (2017-2028)
• 10.4 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country
  • 10.4.1 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022)
  • 10.4.2 Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Ipsen SA
  • 11.1.1 Ipsen SA Company Details
  • 11.1.2 Ipsen SA Business Overview
  • 11.1.3 Ipsen SA Prostate Cancer Diagnostics and Therapy Introduction
  • 11.1.4 Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.1.5 Ipsen SA Recent Developments
• 11.2 Pfizer Inc.
  • 11.2.1 Pfizer Inc. Company Details
  • 11.2.2 Pfizer Inc. Business Overview
  • 11.2.3 Pfizer Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.2.4 Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.2.5 Pfizer Inc. Recent Developments
• 11.3 Johnson & Johnson Services Inc.
  • 11.3.1 Johnson & Johnson Services Inc. Company Details
  • 11.3.2 Johnson & Johnson Services Inc. Business Overview
  • 11.3.3 Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.3.4 Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.3.5 Johnson & Johnson Services Inc. Recent Developments
• 11.4 Bayer AG
  • 11.4.1 Bayer AG Company Details
  • 11.4.2 Bayer AG Business Overview
  • 11.4.3 Bayer AG Prostate Cancer Diagnostics and Therapy Introduction
  • 11.4.4 Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.4.5 Bayer AG Recent Developments
• 11.5 Abbvie Inc.
  • 11.5.1 Abbvie Inc. Company Details
  • 11.5.2 Abbvie Inc. Business Overview
  • 11.5.3 Abbvie Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.5.4 Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.5.5 Abbvie Inc. Recent Developments
• 11.6 Merck & Co. Inc.
  • 11.6.1 Merck & Co. Inc. Company Details
  • 11.6.2 Merck & Co. Inc. Business Overview
  • 11.6.3 Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.6.4 Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.6.5 Merck & Co. Inc. Recent Developments
• 11.7 AstraZeneca PLC
  • 11.7.1 AstraZeneca PLC Company Details
  • 11.7.2 AstraZeneca PLC Business Overview
  • 11.7.3 AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Introduction
  • 11.7.4 AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.7.5 AstraZeneca PLC Recent Developments
• 11.8 Thermo Fisher Scientific
  • 11.8.1 Thermo Fisher Scientific Company Details
  • 11.8.2 Thermo Fisher Scientific Business Overview
  • 11.8.3 Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Introduction
  • 11.8.4 Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.8.5 Thermo Fisher Scientific Recent Developments
• 11.9 Dendreon Pharmaceuticals LLC
  • 11.9.1 Dendreon Pharmaceuticals LLC Company Details
  • 11.9.2 Dendreon Pharmaceuticals LLC Business Overview
  • 11.9.3 Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Introduction
  • 11.9.4 Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.9.5 Dendreon Pharmaceuticals LLC Recent Developments
• 11.10 F. Hoffmann-La Roche Ltd
  • 11.10.1 F. Hoffmann-La Roche Ltd Company Details
  • 11.10.2 F. Hoffmann-La Roche Ltd Business Overview
  • 11.10.3 F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Introduction
  • 11.10.4 F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.10.5 F. Hoffmann-La Roche Ltd Recent Developments
• 11.11 Hologic Inc.
  • 11.11.1 Hologic Inc. Company Details
  • 11.11.2 Hologic Inc. Business Overview
  • 11.11.3 Hologic Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.11.4 Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.11.5 Hologic Inc. Recent Developments
• 11.12 Astellas Pharma Inc.
  • 11.12.1 Astellas Pharma Inc. Company Details
  • 11.12.2 Astellas Pharma Inc. Business Overview
  • 11.12.3 Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Introduction
  • 11.12.4 Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.12.5 Astellas Pharma Inc. Recent Developments
• 11.13 Koninklijke Philips NV
  • 11.13.1 Koninklijke Philips NV Company Details
  • 11.13.2 Koninklijke Philips NV Business Overview
  • 11.13.3 Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Introduction
  • 11.13.4 Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.13.5 Koninklijke Philips NV Recent Developments
• 11.14 Sanofi-Aventis
  • 11.14.1 Sanofi-Aventis Company Details
  • 11.14.2 Sanofi-Aventis Business Overview
  • 11.14.3 Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Introduction
  • 11.14.4 Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
  • 11.14.5 Sanofi-Aventis Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Author Details
• 13.3 Disclaimer

• Table 1. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Treatment Method (US$ Million), 2017 VS 2021 VS 2028
• Table 2. Key Players of Androgen Receptor-Directed Therapy
• Table 3. Key Players of Taxane-Based Chemotherapy
• Table 4. Global Prostate Cancer Diagnostics and Therapy Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
• Table 5. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
• Table 6. Global Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & (US$ Million)
• Table 7. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2017-2022)
• Table 8. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
• Table 9. Global Prostate Cancer Diagnostics and Therapy Market Share by Region (2023-2028)
• Table 10. Prostate Cancer Diagnostics and Therapy Market Trends
• Table 11. Prostate Cancer Diagnostics and Therapy Market Drivers
• Table 12. Prostate Cancer Diagnostics and Therapy Market Challenges
• Table 13. Prostate Cancer Diagnostics and Therapy Market Restraints
• Table 14. Global Prostate Cancer Diagnostics and Therapy Revenue by Players (2017-2022) & (US$ Million)
• Table 15. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Players (2017-2022)
• Table 16. Global Top Prostate Cancer Diagnostics and Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2021)
• Table 17. Ranking of Global Top Prostate Cancer Diagnostics and Therapy Companies by Revenue (US$ Million) in 2021
• Table 18. Global 5 Largest Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue (CR5 and HHI) & (2017-2022)
• Table 19. Key Players Headquarters and Area Served
• Table 20. Key Players Prostate Cancer Diagnostics and Therapy Product Solution and Service
• Table 21. Date of Enter into Prostate Cancer Diagnostics and Therapy Market
• Table 22. Mergers & Acquisitions, Expansion Plans
• Table 23. Global Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 24. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Treatment Method (2017-2022)
• Table 25. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 26. Global Prostate Cancer Diagnostics and Therapy Revenue Market Share by Treatment Method (2023-2028)
• Table 27. Global Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 28. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Application (2017-2022)
• Table 29. Global Prostate Cancer Diagnostics and Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
• Table 30. Global Prostate Cancer Diagnostics and Therapy Revenue Share by Application (2023-2028)
• Table 31. North America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 32. North America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 33. North America Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 34. North America Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028) & (US$ Million)
• Table 35. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
• Table 36. North America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
• Table 37. Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 38. Europe Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 39. Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 40. Europe Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028) & (US$ Million)
• Table 41. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
• Table 42. Europe Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
• Table 43. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 44. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 45. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 46. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028) & (US$ Million)
• Table 47. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2017-2022) & (US$ Million)
• Table 48. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size by Region (2023-2028) & (US$ Million)
• Table 49. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 50. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 51. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 52. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028) & (US$ Million)
• Table 53. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
• Table 54. Latin America Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
• Table 55. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2017-2022) & (US$ Million)
• Table 56. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Treatment Method (2023-2028) & (US$ Million)
• Table 57. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2017-2022) & (US$ Million)
• Table 58. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Application (2023-2028) & (US$ Million)
• Table 59. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2017-2022) & (US$ Million)
• Table 60. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size by Country (2023-2028) & (US$ Million)
• Table 61. Ipsen SA Company Details
• Table 62. Ipsen SA Business Overview
• Table 63. Ipsen SA Prostate Cancer Diagnostics and Therapy Product
• Table 64. Ipsen SA Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 65. Ipsen SA Recent Developments
• Table 66. Pfizer Inc. Company Details
• Table 67. Pfizer Inc. Business Overview
• Table 68. Pfizer Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 69. Pfizer Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 70. Pfizer Inc. Recent Developments
• Table 71. Johnson & Johnson Services Inc. Company Details
• Table 72. Johnson & Johnson Services Inc. Business Overview
• Table 73. Johnson & Johnson Services Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 74. Johnson & Johnson Services Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 75. Johnson & Johnson Services Inc. Recent Developments
• Table 76. Bayer AG Company Details
• Table 77. Bayer AG Business Overview
• Table 78. Bayer AG Prostate Cancer Diagnostics and Therapy Product
• Table 79. Bayer AG Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 80. Bayer AG Recent Developments
• Table 81. Abbvie Inc. Company Details
• Table 82. Abbvie Inc. Business Overview
• Table 83. Abbvie Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 84. Abbvie Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 85. Abbvie Inc. Recent Developments
• Table 86. Merck & Co. Inc. Company Details
• Table 87. Merck & Co. Inc. Business Overview
• Table 88. Merck & Co. Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 89. Merck & Co. Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 90. Merck & Co. Inc. Recent Developments
• Table 91. AstraZeneca PLC Company Details
• Table 92. AstraZeneca PLC Business Overview
• Table 93. AstraZeneca PLC Prostate Cancer Diagnostics and Therapy Product
• Table 94. AstraZeneca PLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 95. AstraZeneca PLC Recent Developments
• Table 96. Thermo Fisher Scientific Company Details
• Table 97. Thermo Fisher Scientific Business Overview
• Table 98. Thermo Fisher Scientific Prostate Cancer Diagnostics and Therapy Product
• Table 99. Thermo Fisher Scientific Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 100. Thermo Fisher Scientific Recent Developments
• Table 101. Dendreon Pharmaceuticals LLC Company Details
• Table 102. Dendreon Pharmaceuticals LLC Business Overview
• Table 103. Dendreon Pharmaceuticals LLC Prostate Cancer Diagnostics and Therapy Product
• Table 104. Dendreon Pharmaceuticals LLC Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 105. Dendreon Pharmaceuticals LLC Recent Developments
• Table 106. F. Hoffmann-La Roche Ltd Company Details
• Table 107. F. Hoffmann-La Roche Ltd Business Overview
• Table 108. F. Hoffmann-La Roche Ltd Prostate Cancer Diagnostics and Therapy Product
• Table 109. F. Hoffmann-La Roche Ltd Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 110. F. Hoffmann-La Roche Ltd Recent Developments
• Table 111. Hologic Inc. Company Details
• Table 112. Hologic Inc. Business Overview
• Table 113. Hologic Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 114. Hologic Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 115. Hologic Inc. Recent Developments
• Table 116. Astellas Pharma Inc. Company Details
• Table 117. Astellas Pharma Inc. Business Overview
• Table 118. Astellas Pharma Inc. Prostate Cancer Diagnostics and Therapy Product
• Table 119. Astellas Pharma Inc. Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 120. Astellas Pharma Inc. Recent Developments
• Table 121. Koninklijke Philips NV Company Details
• Table 122. Koninklijke Philips NV Business Overview
• Table 123. Koninklijke Philips NV Prostate Cancer Diagnostics and Therapy Product
• Table 124. Koninklijke Philips NV Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 125. Koninklijke Philips NV Recent Developments
• Table 126. Sanofi-Aventis Company Details
• Table 127. Sanofi-Aventis Business Overview
• Table 128. Sanofi-Aventis Prostate Cancer Diagnostics and Therapy Product
• Table 129. Sanofi-Aventis Revenue in Prostate Cancer Diagnostics and Therapy Business (2017-2022) & (US$ Million)
• Table 130. Sanofi-Aventis Recent Developments
• Table 131. Research Programs/Design for This Report
• Table 132. Key Data Information from Secondary Sources
• Table 133. Key Data Information from Primary Sources

List of Figures

• Figure 1. Global Prostate Cancer Diagnostics and Therapy Market Share by Treatment Method: 2021 VS 2028
• Figure 2. Androgen Receptor-Directed Therapy Features
• Figure 3. Taxane-Based Chemotherapy Features
• Figure 4. Global Prostate Cancer Diagnostics and Therapy Market Share by Application: 2021 VS 2028
• Figure 5. Hospitals Case Studies
• Figure 6. Clinics Case Studies
• Figure 7. Others Case Studies
• Figure 8. Prostate Cancer Diagnostics and Therapy Report Years Considered
• Figure 9. Global Prostate Cancer Diagnostics and Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
• Figure 10. Global Prostate Cancer Diagnostics and Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
• Figure 11. Global Prostate Cancer Diagnostics and Therapy Market Share by Region: 2021 VS 2028
• Figure 12. Global Prostate Cancer Diagnostics and Therapy Market Share by Players in 2021
• Figure 13. Global Top Prostate Cancer Diagnostics and Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prostate Cancer Diagnostics and Therapy as of 2021)
• Figure 14. The Top 10 and 5 Players Market Share by Prostate Cancer Diagnostics and Therapy Revenue in 2021
• Figure 15. North America Prostate Cancer Diagnostics and Therapy Market Size YoY (2017-2028) & (US$ Million)
• Figure 16. North America Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2028)
• Figure 17. North America Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2028)
• Figure 18. North America Prostate Cancer Diagnostics and Therapy Market Size Share by Country (2017-2028)
• Figure 19. United States Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 20. Canada Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 21. Europe Prostate Cancer Diagnostics and Therapy Market Size YoY (2017-2028) & (US$ Million)
• Figure 22. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2028)
• Figure 23. Europe Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2028)
• Figure 24. Europe Prostate Cancer Diagnostics and Therapy Market Size Share by Country (2017-2028)
• Figure 25. Germany Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 26. France Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 27. U.K. Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 28. Italy Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 29. Russia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 30. Nordic Countries Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 31. Asia-Pacific Prostate Cancer Diagnostics and Therapy Market Size YoY (2017-2028) & (US$ Million)
• Figure 32. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2028)
• Figure 33. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2028)
• Figure 34. Asia Pacific Prostate Cancer Diagnostics and Therapy Market Size Share by Region (2017-2028)
• Figure 35. China Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 36. Japan Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 37. South Korea Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 38. Southeast Asia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 39. India Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 40. Australia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

• Figure 41. Latin America Prostate Cancer Diagnostics and Therapy Market Size YoY (2017-2028) & (US$ Million)
• Figure 42. Latin America Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2028)
• Figure 43. Latin America Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2028)
• Figure 44. Latin America Prostate Cancer Diagnostics and Therapy Market Size Share by Country (2017-2028)
• Figure 45. Mexico Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 46. Brazil Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 47. Middle East & Africa Prostate Cancer Diagnostics and Therapy Market Size YoY (2017-2028) & (US$ Million)
• Figure 48. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Treatment Method (2017-2028)
• Figure 49. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size Market Share by Application (2017-2028)
• Figure 50. Middle East and Africa Prostate Cancer Diagnostics and Therapy Market Size Share by Country (2017-2028)
• Figure 51. Turkey Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 52. Saudi Arabia Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 53. UAE Prostate Cancer Diagnostics and Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
• Figure 54. Ipsen SA Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 55. Pfizer Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 56. Johnson & Johnson Services Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 57. Bayer AG Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 58. Abbvie Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 59. Merck & Co. Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 60. AstraZeneca PLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 62. Dendreon Pharmaceuticals LLC Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 63. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 64. Hologic Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 65. Astellas Pharma Inc. Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 66. Koninklijke Philips NV Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 67. Sanofi-Aventis Revenue Growth Rate in Prostate Cancer Diagnostics and Therapy Business (2017-2022)
• Figure 68. Bottom-up and Top-down Approaches for This Report
• Figure 69. Data Triangulation
• Figure 70. Key Executives Interviewed